DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
0.760
-0.040 (-4.98%)
Sep 11, 2024, 4:00 PM EDT - Market closed
DBV Technologies Revenue
DBV Technologies had revenue of $1.16M in the quarter ending June 30, 2024, a decrease of -49.26%. This brings the company's revenue in the last twelve months to $13.81M, up 163.02% year-over-year. In the year 2023, DBV Technologies had annual revenue of $15.73M with 224.69% growth.
Revenue (ttm)
$13.81M
Revenue Growth
+163.02%
P/S Ratio
n/a
Revenue / Employee
$131,562
Employees
105
Market Cap
81.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
Dec 31, 2019 | 14.71M | 3.52M | 31.49% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.40B |
So-Young International | 206.62M |
Aclaris Therapeutics | 32.02M |
Verrica Pharmaceuticals | 13.91M |
Adlai Nortye | 5.00M |
Ikena Oncology | 1.84M |
DBVT News
- 7 days ago - DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report - GlobeNewsWire
- 6 weeks ago - DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 - GlobeNewsWire
- 2 months ago - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - GlobeNewsWire
- 3 months ago - DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 3 months ago - DBV Technologies Announces Plan to Implement ADS Ratio Change - GlobeNewsWire